Ethical Pharmacogenetics in CT

[Guest guest]

Dear Members,

Deontological view of the ethical concerns with

pharmacogenomics.

1)

Duty

upon which many western nations, especially the United States, were founded:

the duty to uphold the principles of egalitarianism and equality. In the field

of medicine, this dictates that all members of society must have some access to

effective treatments/medications, and that no particular group within society

be excluded from having access to effective treatments.

2)

Justice is another deontological ideal that

must be addressed; that is, those who are equal in all morally relevant way

must be treated equally, and those who are unequal in some morally relevant way

must be treated unequally (Smart 2004).

3)

Personal

sovereignty and privacy must be reasonably maintained in all uses of

pharmacogenomics.

4)

Duties

to protect the health of individuals and not to endanger them. Each of these

issues is encountered in the analysis of the ethical issues surrounding

pharmacogenomics that will follow.

RegardsDr Sanjay Yallappa ChoudhariJR2,Dept of PharmacologyGMC, Nagpur

The INTERNET now has a personality. YOURS! See your Homepage.